Price, volume, insider information, corporate actions etc.
Using mathematical pattern recognition, statistical optimization and behavioural finance
Daily across the stocks, indices and commodities that matter most to your portfolio
since 1997
average annual return
stock exchanges
stocks, indices, currencies, cryptocurrencies and commodities
Investor
Everything you need to start planning your investment decisions.
€
27
€
16
/ month
Billed Annually: € 199
OrderTrader
Take your investment decisions to another level with short term analyses and more advanced tools.
€
59
€
35
/ month
Billed Annually: € 429
OrderProfessional
A wide range of advanced selection tools and overall analysis to scale your investments.
€
149
€
93
/ month
Billed Annually: € 1119
OrderInstitutional
Access to all 30,000 stocks, commodities and currencies, suited for experienced investment strategists.
Healthcare |
Drug Manufacturers |
Drug Manufacturers - Specialty & Generic |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.